overall andparticularly in trials not funded by the pharmaceutical industry, exogenous testosterone increased the risk of cardiovascular-related events, with corresponding implications for the use of testosterone therapy.” [emphasis added.]
Male to female, or MTF, and female to male, or FTM, transgender people with gender dysphoria require hormone therapy to transition. For FTMs, this involves usingtestosterone. The hormone comes in injections, topical creams or gels, implants or oral medications. Testosterone comes in many forms, ...